In order to further test the relevance of in vivo role of CCL20/CCR6 axis in prostate cancer development, we first evaluated the expression of CCL20 and CCR6 in human prostate cancer tissues with the use of commercially available array of 52 paraffin-embedded prostate sections from patients with advanced prostate cancer. Here, CCR6 is linked to Familial prostate cancer.